Teleflex (NYSE: TFX)+
announced today that it received FDA 510(k) clearance for its AC Range intra-aortic balloon pump (IABP).

The judge vacated the FDA’s final rule, which was strongly opposed by the laboratory industry, and remanded the matter to HHS Secretary Robert F. Kennedy Jr.

WARSAW, Ind., and ZUG, Switzerland, April 1, 2025 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a global medical technology leader, today announced its RibFix Advantage® Fixation System has received CE Mark certification – the first CE Mark for an intrathoracic rib fixation system.

Boston Scientific (NYSE: BSX) has received FDA clearance for its Bolt intravascular lithotripsy (IVL) system, according to the FDA’s 510(k) database.

WASHINGTON, March 31, 2025 /PRNewswire/ — MedStar Georgetown University Hospital is the first hospital in the Washington, D.C. region to offer bedside intestinal ultrasound (IUS) to monitor inflammation in IBD patients. To assess chronic inflammatory diseases of the intestines, like Crohn’s disease and ulcerative colitis, patients are traditionally monitored with blood tests, stool studies, MRI or CT scans, and colonoscopies. Those kinds of tests can require bowel preparation, sedation, anesthesia, and radiation.

PARIS, March 31, 2025 /PRNewswire/ — AZmed, one of the leading AI companies in medical imaging, today announced that it has received two new U.S. Food and Drug Administration (FDA) clearances for its AI tool AZchest. The clearances include applications intended to assist radiologists in the interpretation and detection of chest X-rays for lung nodules and triage capabilities for pneumothorax and pleural effusion.

With PFA becoming physicians’ preferred ablation method for treating AFib, Abbott is pushing to catch up with rival systems already on the market.

Device goes beyond the buzz to create a sophisticated variety of haptic sensations